ArticleCureus2026

Efficacy and Safety of Low-Dose Versus Standard-Dose Immunotherapy in Advanced Solid Tumours: A Retrospective Real-World Study From a Resource-Constrained Setting.

Ajay Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.